Donepezil Hydrochloride Tablets

Jump to

Glenmark, Sun Pharma, Unichem Lab up 1-6% on USFDA approval

Sun Pharmaceutical Industries has received tentative USFDA nod for Dalfampridine tablets.
Lupin shares gain 2% on anti-dementia medicine launch in US

"US subsidiary Lupin Pharmaceuticals Inc has launched its Donepezil hydrochloride tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market," says the pharma major in its filing.
Jubilant Life receives US FDA approval for tablets

Jubilant Life Sciences has received US FDA approval for Donepezil Hydrochloride tablets 5mg & 10 mg, reports CNBC-TV18. It touched an intraday high of Rs 169.45 and an intraday low of Rs 163. At 10:14 hrs the share was quoting at Rs 165.90, up Rs 5.15, or 3.20%.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Donepezil Hydrochloride Tablets

Glenmark, Sun Pharma, Unichem Lab up 1-6% on USFDA approval

Lupin shares gain 2% on anti-dementia medicine launch in US

Jubilant Life receives US FDA approval for tablets